CAPR News

Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel

CAPR Investor Alert: Capricor Therapeutics Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Securities Investigation

Levi & Korsinsky Announces Investigation of Securities Claims Against Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)

Rosen Law Firm Encourages Capricor Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - CAPR

Capricor Therapeutics Investigated For Securities Fraud; Block & Leviton Encourages Investors to Contact The Firm to Possibly Recover Losses

CAPR Investor Alert: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. (CAPR) for Potential Securities Fraud

CAPR Alert: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Urged to Contact Hagens Berman; Investigation Opened Following Massive Stock Crash

CAPR SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. For Possible Securities Law Violations